| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating | 
|---|
																	Mad Money Lightning Round: Jim Cramer says Sempra (SRE) is a buy, supported by Wells Fargo's Overweight rating. Pfizer (PFE...
																	Wells Fargo analyst Shahriar Pourreza initiates coverage on Sempra (NYSE:SRE) with a Overweight rating and announces Price T...
																	Jefferies analyst Julien Dumoulin-Smith maintains Sempra (NYSE:SRE) with a Hold and raises the price target from $87 to $89.
																	BMO Capital analyst James Thalacker maintains Sempra (NYSE:SRE) with a Outperform and raises the price target from $95 to $99.
																	
																	
																	Barclays analyst Nicholas Campanella upgrades Sempra (NYSE:SRE) from Equal-Weight to Overweight and raises the price target ...
																	
																	Evercore ISI Group analyst Nicholas Amicucci initiates coverage on Sempra (NYSE:SRE) with a Outperform rating and announces ...